|
|
|
|
P Chen, H Xie and A Wells
Department of Pathology, University of Alabama at Birmingham 35294- 0007, USA.
We recently demonstrated that epidermal growth factor receptor (EGFR)- mediated signaling of cell motility and mitogenesis diverge at the immediate post-receptor level. How these two mutually exclusive cell responses cross-communicate is not known. We investigated a possible role for a phospholipase C (PLC)-dependent feedback mechanism that attenuates EGF-induced mitogenesis. Inhibition of PLC gamma activation by U73122 (1 microM) augmented the EGF-induced [3H]thymidine incorporation by 23-55% in two transduced NR6 fibroblast lines expressing motility-responsive EGFR; increased cell division and mitosis was observed in parallel. The time dependence of this increase revealed that it was due to an increase in maximal incorporation and not a foreshortened cell cycle. Motility-responsive cell lines expressing a dominant-negative PLC gamma fragment (PLCz) also demonstrated augmented mitogenic responses by 25-68% when compared with control cells. PLCz- or U73122-augmented mitogenesis was not observed in three non-PLC gamma activating, nonmotility-responsive EGFR- expressing cell lines. Protein kinase C (PKC), which may be activated by PLC-generated second messengers, has been proposed as mediating feedback attenuation due to its capacity to phosphorylate EGFR and inhibit the receptor's tyrosine kinase activity. Inhibition of PKC by Calphostin C (0.05 microM) resulted in a 57% augmentation in the fold of EGF-induced thymidine incorporation. To further establish PKC's role in this feedback attenuation mechanism, an EGFR point mutation, in which the PKC target threonine654 was replaced by alanine, was expressed. Cells expressing these PKC-resistant EGFR constructs demonstrated EGF-induced motility comparable to cells expressing the threonine-containing EGFR. However, when these cells were treated with U73122 or Calphostin C, the mitogenic responses are not enhanced. These findings suggest a model in which PKC activation subsequent to triggering of motility-associated PLC gamma activity attenuates the EGFR mitogenic response.
This article has been cited by other articles:
![]() |
K. Tamama, V. H. Fan, L. G. Griffith, H. C. Blair, and A. Wells Epidermal Growth Factor as a Candidate for Ex Vivo Expansion of Bone Marrow-Derived Mesenchymal Stem Cells Stem Cells, March 1, 2006; 24(3): 686 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hurbin, J.-L. Coll, L. Dubrez-Daloz, B. Mari, P. Auberger, C. Brambilla, and M.-C. Favrot Cooperation of Amphiregulin and Insulin-like Growth Factor-1 Inhibits Bax- and Bad-mediated Apoptosis via a Protein Kinase C-dependent Pathway in Non-small Cell Lung Cancer Cells J. Biol. Chem., May 20, 2005; 280(20): 19757 - 19767. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iwabu, K. Smith, F. D. Allen, D. A. Lauffenburger, and A. Wells Epidermal Growth Factor Induces Fibroblast Contractility and Motility via a Protein Kinase C {delta}-dependent Pathway J. Biol. Chem., April 9, 2004; 279(15): 14551 - 14560. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, L. J. Zhang, M. Shaikh, J. Z. Fields, A. Farhadi, and A. Keshavarzian Inhibition of Oxidant-Induced Nuclear Factor-{kappa}B Activation and Inhibitory-{kappa}B{alpha} Degradation and Instability of F-Actin Cytoskeletal Dynamics and Barrier Function by Epidermal Growth Factor: Key Role of Phospholipase-{gamma} Isoform J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 356 - 368. [Abstract] [Full Text] |
||||
![]() |
A. Glading, R. J. Bodnar, I. J. Reynolds, H. Shiraha, L. Satish, D. A. Potter, H. C. Blair, and A. Wells Epidermal Growth Factor Activates m-Calpain (Calpain II), at Least in Part, by Extracellular Signal-Regulated Kinase-Mediated Phosphorylation Mol. Cell. Biol., March 15, 2004; 24(6): 2499 - 2512. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, L. J. Zhang, M. Shaikh, J. Z. Fields, A. Farhadi, and A. Keshavarzian Key role of PLC-{gamma} in EGF protection of epithelial barrier against iNOS upregulation and F-actin nitration and disassembly Am J Physiol Cell Physiol, October 1, 2003; 285(4): C977 - C993. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Meyer, C. Latz, and N. Rahimi Recruitment and Activation of Phospholipase Cgamma 1 by Vascular Endothelial Growth Factor Receptor-2 Are Required for Tubulogenesis and Differentiation of Endothelial Cells J. Biol. Chem., April 25, 2003; 278(18): 16347 - 16355. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shiraha, A. Glading, J. Chou, Z. Jia, and A. Wells Activation of m-Calpain (Calpain II) by Epidermal Growth Factor Is Limited by Protein Kinase A Phosphorylation of m-Calpain Mol. Cell. Biol., April 15, 2002; 22(8): 2716 - 2727. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Villalba, K. Bi, J. Hu, Y. Altman, P. Bushway, E. Reits, J. Neefjes, G. Baier, R. T. Abraham, and A. Altman Translocation of PKC{theta} in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C J. Cell Biol., April 15, 2002; 157(2): 253 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wells, J. C. S. Souto, J. Solava, J. Kassis, K. J. Bailey, and T. Turner Luteinizing Hormone-releasing Hormone Agonist Limits DU-145 Prostate Cancer Growth by Attenuating Epidermal Growth Factor Receptor Signaling Clin. Cancer Res., April 1, 2002; 8(4): 1251 - 1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mariotti, P. A. Kedeshian, M. Dans, A. M. Curatola, L. Gagnoux-Palacios, and F. G. Giancotti EGF-R signaling through Fyn kinase disrupts the function of integrin {alpha}6{beta}4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion J. Cell Biol., October 29, 2001; 155(3): 447 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, J. Z. Fields, Y. Zhang, and A. Keshavarzian Phospholipase C-{gamma} inhibition prevents EGF protection of intestinal cytoskeleton and barrier against oxidants Am J Physiol Gastrointest Liver Physiol, August 1, 2001; 281(2): G412 - G423. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Botelho, M. Teruel, R. Dierckman, R. Anderson, A. Wells, J. D. York, T. Meyer, and S. Grinstein Localized Biphasic Changes in Phosphatidylinositol-4,5-Bisphosphate at Sites of Phagocytosis J. Cell Biol., December 18, 2000; 151(7): 1353 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Adelsman, J. B. McCarthy, and Y. Shimizu Stimulation of beta 1-Integrin Function by Epidermal Growth Factor and Heregulin-beta Has Distinct Requirements for erbB2 but a Similar Dependence on Phosphoinositide 3-OH Kinase Mol. Biol. Cell, September 1, 1999; 10(9): 2861 - 2878. [Abstract] [Full Text] |
||||
![]() |
H. Shiraha, A. Glading, K. Gupta, and A. Wells IP-10 Inhibits Epidermal Growth Factor–induced Motility by Decreasing Epidermal Growth Factor Receptor–mediated Calpain Activity J. Cell Biol., July 12, 1999; 146(1): 243 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Miranti, S. Ohno, and J. S. Brugge Protein Kinase C Regulates Integrin-induced Activation of the Extracellular Regulated Kinase Pathway Upstream of Shc J. Biol. Chem., April 9, 1999; 274(15): 10571 - 10581. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wong, T. B. Deb, S. A. Thompson, A. Wells, and G. R. Johnson A Differential Requirement for the COOH-terminal Region of the Epidermal Growth Factor (EGF) Receptor in Amphiregulin and EGF Mitogenic Signaling J. Biol. Chem., March 26, 1999; 274(13): 8900 - 8909. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Haugh, K. Schooler, A. Wells, H. S. Wiley, and D. A. Lauffenburger Effect of Epidermal Growth Factor Receptor Internalization on Regulation of the Phospholipase C-gamma 1 Signaling Pathway J. Biol. Chem., March 26, 1999; 274(13): 8958 - 8965. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Soltoff Related Adhesion Focal Tyrosine Kinase and the Epidermal Growth Factor Receptor Mediate the Stimulation of Mitogen-activated Protein Kinase by the G-protein-coupled P2Y2 Receptor. PHORBOL ESTER OR [Ca2+]i ELEVATION CAN SUBSTITUTE FOR RECEPTOR ACTIVATION J. Biol. Chem., September 4, 1998; 273(36): 23110 - 23117. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-s. Ji, S. Ermini, J. Baulida, F.-l. Sun, and G. Carpenter Epidermal Growth Factor Signaling and Mitogenesis in Plcg1 Null Mouse Embryonic Fibroblasts Mol. Biol. Cell, April 1, 1998; 9(4): 749 - 757. [Abstract] [Full Text] |
||||
![]() |
C. S. Swindle, K. T. Tran, T. D. Johnson, P. Banerjee, A. M. Mayes, L. Griffith, and A. Wells Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor J. Cell Biol., July 23, 2001; 154(2): 459 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shiraha, K. Gupta, K. Drabik, and A. Wells Aging Fibroblasts Present Reduced Epidermal Growth Factor (EGF) Responsiveness Due to Preferential Loss of EGF Receptors J. Biol. Chem., June 16, 2000; 275(25): 19343 - 19351. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. von Lindern, M. P.-v. Amelsvoort, T. van Dijk, E. Deiner, E. van den Akker, S. van Emst-de Vries, P. Willems, H. Beug, and B. Lowenberg Protein Kinase C alpha Controls Erythropoietin Receptor Signaling J. Biol. Chem., October 27, 2000; 275(44): 34719 - 34727. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Maheshwari, H. S. Wiley, and D. A. Lauffenburger Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration J. Cell Biol., December 24, 2001; 155(7): 1123 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Villalba, K. Bi, J. Hu, Y. Altman, P. Bushway, E. Reits, J. Neefjes, G. Baier, R. T. Abraham, and A. Altman Translocation of PKC{theta} in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C J. Cell Biol., April 15, 2002; 157(2): 253 - 263. [Abstract] [Full Text] [PDF] |
||||